Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Blood|May 23, 1998
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemiaS Legras, U Günthert, R Stauder, et al.
Leukemia|November 1, 1996
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I studyP Sonneveld, J P Marie, C Huisman, et al.
Leukemia|June 1, 1993
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL)J P Marie, J N Bastie, F Coloma, et al.
Leukemia Research|January 1, 1985
DNA ligases in human leukemiaJ C David, R Zittoun, T Bassez, et al.
Annals of Hematology|February 1, 1997
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatmentM Hunault, D Zhou, A Delmer, et al.
Leukemia|April 3, 2009
Vasculogenic mimicry of acute leukemic bone marrow stromal cellsP Mirshahi, A Rafii, L Vincent, et al.
Leukemia|October 17, 2003
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002R A Larson, G Q Daley, C A Schiffer, et al.
Hematology and Cell Therapy|April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemiaE Archimbaud, V Leblond, P Fenaux, et al.
Annals of Hematology|April 1, 2014
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|February 21, 2025
Harvesting, revascularization and innervation of a laryngeal transplantS Vergez, O Malard, F Jegoux, et al.
Pageof 23